HBI
53
4
ILMN
31
4
PWR
63
3
INTC
35
4
GWW
50
9
RCL
74
5
AMT
30
2
CAT
47
3
ORCL
49
3
WAT
55
11
ED
39
8
AMG
33
-11
DRI
74
5
CI
35
2
TMO
52
8
ACN
54
2
F
38
4
JBHT
46
4
CA
19
6
DD
44
2
HBI
53
4
ILMN
31
4
PWR
63
3
INTC
35
4
GWW
50
9
RCL
74
5
AMT
30
2
CAT
47
3
ORCL
49
3
WAT
55
11
ED
39
8
AMG
33
-11
DRI
74
5
CI
35
2
TMO
52
8
ACN
54
2
F
38
4
JBHT
46
4
CA
19
6
DD
44
2
Financhill
Back

RE/MAX Holdings 10K Form

Sell
37

RMAX
RE/MAX Holdings

Last Price:
$11.07
Seasonality Move:
-5.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RMAX News And Ratings

See the #1 stock for the next 7 days that we like better than RMAX

RMAX Financial Statistics

Sales & Book Value

Annual Sales: $325.7M
Cash Flow: $16.3M
Price / Cash Flow: 4.78
Annual Sales: $22.42
Price / Book: 0.49

Profitability

EPS (TTM): -0.53000
Net Income (TTM): $-9.6M
Gross Margin: $241.8M
Return on Equity: 0%
Return on Assets: -1.66%

RE/MAX Holdings Earnings Forecast

Key RE/MAX Holdings Financial Ratios

  • The Gross Profit Margin over the past 11 years for RMAX is 74.25%.
  • The Selling, General & Administrative Expenses for RMAX have been equal to 52.68% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -51.78% of Operating Income.
  • The Net Earning history of RMAX is -21.19% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 6 years.

RE/MAX Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Real Estate Management & Development
Sector: Real Estate
Current Symbol: RMAX
CUSIP: 75524W
Website: remax.com

Debt

Debt-to-Equity Ratio: 1.04
Current Ratio: 1.37
Quick Ratio: 0.79

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 8.4

RMAX Technical Analysis vs Fundamental Analysis

Sell
37
RE/MAX Holdings (RMAX) is a Sell

Is RE/MAX Holdings a Buy or a Sell?

  • RE/MAX Holdings stock is rated a Sell
    The current RE/MAX Holdings [RMAX] share price is $11.05. The Score for RMAX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.